Epigenetic Erasers

Important players in the removal of “epigenetic signatures” or post translational modifications on histones are epigenetic erasers.

Epigenetic Erasers from BioVision

These epigenetic reprogramming events are needed during a number of developmental stages. BioVision provides a number of epigenetic erasers and some of them are potential targets for cancer therapeutics.

The balance of histone acetylation and deacetylation plays a key part in transcription regulation. HDAC activity is associated with the gene silencing part of this regulation. Mutation in HDAC structure and alteration in expression has been associated with tumor development, leading to  HDACs being a cancer therapeutic target.

About BioVision Incorporated

BioVision, Inc., is a privately held Life Science company headquartered in the beautiful San Francisco Bay Area.

BioVision develops and offers a wide variety of products including assay kits, antibodies, recombinant proteins & enzymes, and other innovative research tools for studying Apoptosis, Metabolism, Cell Proliferation, Cellular Stress, Cell Damage and Repair, Diabetes, Obesity and Metabolic Syndrome, Stem Cell Biology, Gene Regulation, Signal Transduction, etc. BioVision's products are currently being sold in more than 60 countries worldwide.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Last updated: May 23, 2019 at 12:03 PM

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    BioVision Incorporated. (2019, May 23). Epigenetic Erasers. News-Medical. Retrieved on January 17, 2020 from https://www.news-medical.net/whitepaper/20190523/Epigenetic-Erasers.aspx.

  • MLA

    BioVision Incorporated. "Epigenetic Erasers". News-Medical. 17 January 2020. <https://www.news-medical.net/whitepaper/20190523/Epigenetic-Erasers.aspx>.

  • Chicago

    BioVision Incorporated. "Epigenetic Erasers". News-Medical. https://www.news-medical.net/whitepaper/20190523/Epigenetic-Erasers.aspx. (accessed January 17, 2020).

  • Harvard

    BioVision Incorporated. 2019. Epigenetic Erasers. News-Medical, viewed 17 January 2020, https://www.news-medical.net/whitepaper/20190523/Epigenetic-Erasers.aspx.

Other White Papers by this Supplier